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Thestaphylococcalbipartiteleukotoxinsandthehomoheptamericα-toxinbelongtothesamefamilyofβ-barrelpore-formingtox-
ins despite slight diﬀerences. In the α-toxin pore, the N-terminal extremity of each protomer interacts as a deployed latch with two
consecutive protomers in the vicinity of the pore lumen. N-terminal extremities of leukotoxins as seen in their three-dimensional
structures are heterogeneous in length and take part in the β-sandwich core of soluble monomers. Hence, the interaction of these
N-terminal extremities within structures of adjacent monomers is questionable. We show here that modiﬁcations of their N-
termini by two diﬀerent processes, using fusion with glutathione S-transferase (GST) and bridging of the N-terminal extremity to
the adjacent β-sheet via disulphide bridges, are not deleterious for biological activity. Therefore, bipartite leukotoxins do not need
a large extension of their N-terminal extremities to form functional pores, thus illustrating a microheterogeneity of the structural
organizations between bipartite leukotoxins and α-toxin.
Copyright © 2007 Olivier Joubert et al.ThisisanopenaccessarticledistributedundertheCreativeCommonsAttributionLicense,
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
1. INTRODUCTION
Staphylococcal bipartite leukotoxins and α-toxin belong to a
single family of structurally related β-stranded pore-forming
toxins (Figure 1). Leukotoxins are constituted by a class S
protein (32kd) that binds to the surface of target cells prior
to a class F protein (34kd) distinct in sequence [1]. Then,
these proteins oligomerise to octamers or hexamers [2–5],
induce Ca2+-activation [6], and form monovalent cation-
selective β-barrel transmembrane pores [7]. Each protomer
contributes to the pore by transforming a central β-sheet
domain into a β-hairpin [8, 9]. Five loci encoding leuko-
toxins are characterized [9]. Several of these loci, encoding
the Panton-Valentine leucocidin (PVL), gamma-hemolysin,
[10] and LukE-LukD [11], may be present together and are
expressed in a single isolate. The S and F components can
then combine to give a speciﬁc leukotoxin. However, they do
not combine with α-toxin, also present in almost all isolates,
for an action onto natural target cells [12], that is, human
polymorphonuclear cells or erythrocytes. Panton-Valentine
leucocidin, which is composed of LukS-PV and LukF-PV, is
associated with furuncles [13] and pneumonia [14]. Bipar-
tite leukotoxins show a complementary spectrum for lytic
functions towards human blood cells including lymphocytes
and erythrocytes, accounting for the bacterial virulence. Fur-
thermore, leukotoxins and α-toxin diﬀer from each other by
the respective cationic and anionic selectivities of their pores
[6, 15, 16].
X-ray diﬀraction and other techniques have been used
to study the heptameric pore of α-toxin [17–21]. The crys-
tal structure of the assembled α-toxin [20] revealed that the
transmembrane β-barrel that forms the pore corresponds2 Journal of Biomedicine and Biotechnology
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Figure 1: Structural features of the N-terminal extremities of staphylococcal bipartite leukotoxins and α-toxin. (a) Sequence alignment of
the N-termini of staphylococcal α-toxin and of the two components LukF-PV and LukS-PV of the Panton-Valentine leucocidin. The strands
arrangement of LukF-PV is indicated by dashes. Cysteine-substituted residues, indicated in bold in the sequences, are also shown on the 3D
structures of LukF-PV (PDB code 1pvl) and LukS-PV (PDB code 1t5r). (b) For comparison, view three protomers of the α-toxin heptamer
(PDBcode7AHL)andpolarinteractionsinvolvingtheN-terminalextremityofagivensubunit(red)withresiduesoftwoadjacentprotomers
(grey and dark grey) within the α-toxin pore lumen.
to the stem domain of a mushroom-shaped structure. It
also revealed that the N-terminal extremity, also called the
amino latch, of each protomer interacts with two adjacent
protomers in the mouth of the pore lumen. The 3D struc-
tures of the soluble form of two F monomers, LukF-PV from
the Panton-Valentine leucocidin (Figure 1(a))[ 8] and HlgB
from gamma-hemolysin [22], have also been determined.
They showed that the central stem domain is prefolded as
three β-strands stacked to the core of the soluble proteins.
This core is formed of a β-sandwich to which the N-terminal
extremity of the soluble F proteins contributes to one strand.
Despite the high similarity between the F and S structures,
the N-terminal extremity of LukS-PV appeared shorter [23].
The F and S proteins must undergo a number of confor-
mational modiﬁcations during oligomerization and β-barrel
formation to evolve to a functional transmembrane pore
[24, 25].
Since the possible unfolding of the N-terminal extrem-
ity to interact with adjacent subunits is unclear, and that
modifying the N-termini for bioengineering purposes could
considerably inﬂuence their function, we report that some
biological activity is retained by recombinant proteins after
glutathione S-transferase (GST) fusion and expression in Es-
cherichiacoli.Wealsoconstrainedthisportionoftheproteins
to the β-sandwich by engineering disulﬁde bonds, and inves-
tigated the residual functions of new leukotoxins in order to
verify if N-terminal extremities of leukotoxins must explore
a large conformational space for their pore-forming activity.
2. MATERIALS AND METHODS
2.1. Bacterialstrainsandvectors
Escherichia coli XL1 blue cells (recA1 endA1 gyrA96 thi1
hsdR17 supE44 relA1 lac (F’ proAB lacIqZΔM15 Tn10 (tetr)))
(Stratagene, Amsterdam, The Netherlands) were used as re-
cipient cells for transformation with recombinant pGEX-
6P-1 following site-directed mutagenesis. E. coli BL21 (F−,
ompT, hsdS (rB−, mB−), gal) was used for overexpression
of the glutathione-S-transferase (GST)—leukotoxin fusion
genes, according to Manufacturer’s instructions (Ge Health-
c a r e ,U S A )[ 24].
2.2. Choice,construction,andpuriﬁcation
ofmodiﬁedproteins
We considered alignment of N-terminal LukS-PV and LukF-
PV sequence alignment extracted from the alignment of
entire sequences (Figure 1(a))[ 23]. We chose two pairs of
LukF-PV amino acids, T5 and T21, and S8 and K20 for
cysteine substitutions due to their respective close locations
in the structure (Figure 1(a))[ 8]. The distance between Cβ
a t o m so fT 5a n dT 2 1( 5 . 7˚ A) and angles between thiol groups
mayallowtheformationofdisulﬁdebondsthatwouldbridgeOlivier Joubert et al. 3
the ﬁrst two β-strands of the protein (SSBond software,
[26]). The other pair of amino acids seemed even more
favorable for disulphide bridge formation, with a distance
between Cβ atoms of 4.1 ˚ A.
ThesituationwaslessobviousforLukS-PV,whichhasno
counterpart to LukF-PV T5 (Figure 1(a)). Furthermore, the
ﬁrst three amino acids of the shorter LukS-PV N-terminal
extremity could not be traced in the crystal structures of ei-
ther wild type [23] or recombinant protein (unpublished re-
sults). Therefore, this N-terminal extremity may be poorly
structured. To allow bridging with R16, which can be aligned
with T21 of LukF-PV, we ﬁnally chose to substitute either
LukS-PV N2 or D1 by a cysteine, and to introduce an-
other cysteine residue upstream from D1 (called LukS-PV-
1C) (Figure 1(a)).
Open reading frames corresponding to the secreted
LukF-PV and LukS-PV encoding genes were previously
cloned into the pGEX-6P-1 expression vector [24]. We fur-
ther obtained ﬁve double mutants, LukS-PV(-1C)-R16C,
D1C-R16C, N2C-R16C and LukF-PV T5C-T21C, S8C-
K20C, using dedicated oligonucleotides in a two-step muta-
genesis procedure similar to that of Quick Change mutage-
nesis (Stratagene, Calif., USA), except that Pfu Turbo DNA
polymerase was replaced by Arrow Taq DNA polymerase,
and T4 GP32 protein (Qbiogene Inc., Calif, USA).
GST∼LukS-PV and GST∼LukF-PV fusion proteins were
puriﬁed for functional analysis by chromatography on
glutathione-sepharose 4B followed by hydrophobic in-
teraction chromatography (HIC, alkyl-superose, i.e., re-
source ISO—Ge Healthcare, USA). GST∼LukS-PV and
GST∼LukF-PV eluted at 0.73M and 0.78M (NH4)2SO4,r e -
spectively. All double cysteine-mutated proteins were puri-
ﬁedbyaﬃnitychromatographyonglutathione-sepharose4B
followed by cation-exchange FPLC chromatography (CEC)
using an NaCl gradient from 0.05M to 0.7M [24]. The
GST-tag was removed thanks to the PreScission protease.
Nevertheless, it remains an octapeptide at the N-terminus
which does not hamper the biological activities of the tox-
ins [8, 24] (Amersham Biosciences). Hydrophobic interac-
tion chromatography (HIC) was further applied using an
(NH4)2SO4 gradient from 1.3M to 0.5M to improve puriﬁ-
cations. LukS-PV mutants eluted at 0.15M NaCl and 1.02M
(NH4)2SO4, whereas those of LukF-PV eluted at 0.1M NaCl
and 0.95M (NH4)2SO4. To avoid any disulﬁde links forma-
tion between free sulfhydryl groups of the cysteine residues
of the fusion proteins and the GSH, all buﬀers used for the
CECandtheHICcontain1mMDTT(exceptforGSTfusion
proteins). Controls for homogeneity were performed using
SDS-PAGE, and the proteins were then stored at −80◦C. We
labelled two fully functional mutants, LukF-PV S27C and
LukS-PV G10C, with ﬂuorescein 5-maleimide (Molecular
Probes, Leiden, The Netherlands) [24].
2.2.1. Oxidationandaccessiblethiol-titration
The cysteine mutants were ﬁrst reduced with 10mM DTT,
before treating with CuSO4, 1,10-phenanthroline (Sigma,
USA). Brieﬂy, proteins at a concentration of 20μMw e r e
dialysed in 50mM Hepes, 0.5M NaCl, 10mM DTT pH 7.5,
a n df u r t h e re q u i l i b r a t e da g a i n s t5 0m MH e p e s ,0 . 5MN a C l ,
pH 7.5 to undergo oxidation. Proteins were then adjusted
to 2mL (20μM) of the same buﬀer complemented with
1.5mM CuSO4, 5mM 1,10-phenanthroline and incubated
for 2 hours at 4◦C. Protein solutions were then equilibrated
against50mMHepes,0.5MNaCl,1mMEDTA-Na2,pH7.5,
and could then be frozen without loss of disulﬁde bonds and
biological activity.
For the titration of free thiols, proteins were precipitated
in 5% (w/v) trichloroacetic acid and left for 5 minutes at
0◦C, pelleted by centrifugation and washed three times with
the same solution. The precipitate was dissolved in 400μL
of N2-saturated 0.2M Hepes, 0.2M NaCl, 1mM EDTA-Na2,
2% (w/v) SDS, pH 8.0. The remaining precipitated mate-
rial (< 10% of total proteins) was removed by centrifuga-
tion and 300μL of the supernatant was added to 30μLo f
10mM 5-5 -di-thio-bis (2-nitro) benzoic acid (DTNB) (ε =
13,600M−1·cm−1). After 10 minutes of reaction at room
temperature, the amount of titrated thiols was estimated by
OD at 412nm and the molarity was compared to the protein
concentration determined by the Lowry method.
2.3. Humanpolymorphonuclearcells(PMNs)andﬂow
cytometrymeasurements
Human PMNs from healthy donors were puriﬁed from buﬀy
coats as previously reported [27], and suspended at 5 ×
105 cells/mL in 10mM Hepes, 140mM NaCl, 5mM KCl,
10mM glucose, 0.1mM EGTA pH 7.3. Flow cytometry mea-
surements from 3000 PMNs were carried out using a Fac-
Sort ﬂow cytometer (Becton-Dickinson, Le Pont de Claix,
France) equipped with an argon laser tuned to 488nm [28].
We evaluated the intracellular calcium using ﬂow cytom-
etry of cells previously loaded with 5μMF l u o - 3( m o l e c -
ular probes) in the presence of 1.1mM extracellular Ca2+
by measuring the increase of Fluo-3 ﬂuorescence. Pore for-
mation and monovalent cation inﬂux were revealed by the
penetration of ethidium through the pores; cells were incu-
bated 30 minutes with 4μM ethidium prior to the addition
of toxins in the absence of extracellular Ca2+ [24, 28]. Fluo-3
and ethidium ﬂuorescence were measured using Cell Quest
Pro software (Becton, Dickinson and Company). The results
from at least four diﬀerent donors were averaged and ex-
pressed as percentages of a control of human PMNs treated
with the wild-type (WT) PVL. Base level values were ob-
tained for each series of data from a control without addition
of toxin. These were systematically subtracted from the other
assays. Standard deviations values never exceeded 10% of the
obtained values; they were removed from ﬁgures for clarity.
The dissociation constant (kD[S]) of LukS-PV for the
PMN membrane and that of LukF-PV for the PMN
membrane-bound LukS-PV (kD[F]) were previously reported
to be 0.07nM and 2.5nM, respectively [29]. LukS-PV and
mutantswereappliedat1nM whileLukF-PVandderivatives
wereappliedat10nMasanexcessoftoxinstotheirligand(s).
The binding properties of the modiﬁed proteins onto PMNs
were estimated through competition experiments carried
out in the absence of extracellular Ca2+. Fluorescein-labelled4 Journal of Biomedicine and Biotechnology
LukS-PV G10C (0.1nM) and LukF-PV S27C (2nM), and
increasing concentrations of the respective mutants (from 1
to 1000nM) were added 15 minutes before measuring the
ﬂuorescence retained at the surface of PMNs. For LukF-PV
competitions, the PMNs were initially incubated for 10 min-
utes with 1nM of LukS-PV. The IC50 value corresponds to
the concentration of nonﬂuorescent competitor needed for
50% cell ﬂuorescence inhibition, and is determined from the
best ﬁt of independent triplicates of the residual cell ﬂuores-
cence [24]. The apparent inhibition constant, kIapp,w a sc a l -
culated from the following equation:
kIapp =
IC50 
1+

S
∗ or F
∗
kD[S] or [F]
,( 1 )
where [S∗ or F∗] are the concentrations of ﬂuorescent LukS-
PV or LukF-PV, and kD[S] or [F] are the dissociation constants
of LukS-PV (0.07nM) or LukF-PV (2.5nM).
2.4. Determinationofporeradius
The pore formation induces a disruption in the cell mem-
brane.Itresultsinanincreaseofthecellsizeduetothediﬀer-
ence of osmolarity between the cytoplasm and the medium.
Indeed, the osmolarity is weaker in the medium than in
the cytoplasm. The relative variations in PMN size were as-
sessedbymeasuringoftheforwardlightscatter(FSC)ofcells
(5×105 cells/ml)treatedwithWTormutant20nMLukS-PV,
WT or mutant 100nM LukF-PV, and 30mM PEG polymers
(1000, 1500, 2000, 3000 Da) of diﬀerent hydrodynamic radii
(0.94, 1.12, 1.22, and 1.44nm, resp.) [25]. FSC values were
collected at 15 minutes after toxin application. If the sizes
of the PEG molecules are similar or greater than the diam-
eter of lumen, they cannot pass through the pores, and then
cannot balance the osmolarity between both compartments.
In that case, the FSC variations are weak. If the sizes of the
PEG molecules are smaller than the diameter of lumen, they
can pass through the pore with balancing the osmolarity be-
tween the two compartments. It results in a rise of the FSC
variations.
2.5. Identiﬁcationofoligomers
Denaturing polyacrylamide gel electrophoresis (SDS-PAGE)
was carried out on oxidized leucotoxin-treated human
PMNs. Preparations at 5 × 107 cells/mL in 10mM Hepes,
140mM NaCl, 5mM KCl, 10mM glucose, 0.1mM EGTA,
pH 7.3, were incubated with 100nM of LukS-PV and LukF-
PV derivatives in the presence of 10μL/mL of a mammalian
cell-tissue antiprotease cocktail (Sigma, USA). After a 45-
minute incubation at 22◦C, the biological activity was as-
sessed by optical microscopy, the cells were washed twice
and then resuspended in 1mL of the same buﬀer containing
an antiprotease cocktail (1μL / m L )a sa b o v e .T h ec e l l sw e r e
ground in a FastPrep apparatus (QBiogene, Bio101, Illkirch,
France) using FastPrep Blue tubes for an orbital centrifuga-
tion (10 seconds, 3600rpm, room temperature). The mem-
branes were harvested by ultracentrifugation for 20 minutes
at 20000×g at 4◦C. The membrane pellets were resuspended
in 100μL of the same buﬀer complemented with 2μLo f
antiprotease cocktail containing 1% (w/v) saponin (Sigma),
incubated for 30 minutes at room temperature and then
centrifuged for 30 minutes at 22000 × g. The supernatants
were adjusted to 1mM glutaraldehyde (in the above buﬀer)
and incubated for 10 minutes at 50◦C. One third volume
of loading buﬀer (0.5M Tris-HCl pH 8.5, 2% (w/v) SDS,
0.04%(w/v)bromophenolblue,30%(v/v)glycerol)contain-
ing 100mM ethanolamine to block the cross-linking reac-
tion was added and assays were heated to 100◦C for 5 min-
utes. Finally, 10μL of the solution was loaded onto Tris-
acetate, pH 8.1 polyacrylamide 3–8% (w/v) gels (Invitro-
gen, Calif, USA). Proteins were subjected to electrophore-
sis for 75 minutes at 150V at room temperature in 50mM
Tris, 50mM Tricine, pH 8.2, 0.1% (w/v) SDS, and then elec-
troblotted onto nitrocellulose membranes for 1 hour at 30V
in 25mM Tris, 192mM glycine, pH 9.3, 20% methanol us-
ing a transfer Xcell II blot module (Invitrogen). The leuko-
toxins oligomers or components were characterized by im-
munoblotting using aﬃnity-puriﬁed rabbit polyclonal anti-
bodies and a peroxidase-labeled goat antirabbit antibody us-
ing ECL detection (Amersham Biosciences, Saclay, France)
as previously described [24]. The apparent molecular masses
were estimated from protein migration according to Preci-
sion Plus Protein Standards (Bio-Rad, USA).
3. RESULTS
3.1. GST-fusionproteinsremainbiologicallyactive
GST∼LukS-PV and GST∼LukF-PV were puriﬁed to homo-
geneity and appeared as homogeneous proteins with appar-
ent molecular masses of 57 and 60kd, because of the fu-
sion with the 26kd GST (Figure 2(a)). The apparent bind-
ing of leukotoxin derivatives with cell membranes was as-
sessed in competition with an increased amount of the func-
tional ﬂuorescein-labelled (∗) LukS-PV G10C∗ or LukF-PV
S27C∗.A pparentkI of0.039nMwasfoundfortheWTLukS-
PV binding to membranes and a value of 3.6nM was found
for the WT LukF-PV binding to LukS-PV-membrane com-
plexes (data not shown). In these conditions, values of kIapp
determined for GST∼LukS-PV and GST∼L u k F - P V( 0 . 2a n d
3.4nM, resp.) remained close to the values obtained for the
WT proteins. However, when GST∼LukF-PV was applied to
the bound GST∼LukS-PV, a kIapp of 17.6nM was recorded,
this marked diﬀerence may be due to some steric hindrance
caused by GST molecules.
Combinations of LukS-PV with GST∼LukF-PV or of
GST∼LukS-PV with LukF-PV led to Ca2+ induction in
treated cells comparable to the WT proteins (Figure 2(b)).
However, the combination of both fusion proteins required a
longertime,thatis,4minutesinsteadof2minutes,toreacha
ﬂuorescence maximum. Subsequent decrease of ﬂuorescence
is mainly due to the release of the ﬂuorescent probe by pores
and disrupted cell membranes.
The permeability to monovalent cations mediated by the
pores was measured via the entry of ethidium and its com-
bination with nucleic acids. Despite ethidium ﬂuorescence
being less sensitive than Ca2+ assay, these two inﬂuxes wereOlivier Joubert et al. 5
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Figure 2: Biological activity of GST fusion proteins. (a) Control of homogeneity by 3%–8% (w/vol) SDS-PAGE of 200ng of each puriﬁed
protein is shown; (1) molecular ladder, (2) LukF-PV, (3) GST∼LukF-PV, (4) LukS-PV, (5) GST∼LukS-PV. (b) Flow cytometry evaluation
of the Ca2+ entry into human PMNs mediated by combinations of wild-type LukS-PV and LukF-PV and GST fusion proteins. (c) Flow cy-
tometry evaluation of the ethidium entry into human PMNs mediated by combinations of LukS-PV and LukF-PV and GST fusion proteins.
(d) Hydrodynamic radius of pores formed by WT and fusion proteins in human PMNs determined after a 30-minute incubation of toxins
(20nM of S and 100nM of F components). Osmotic protection by polyethylene glycol molecules was assessed by variations of the mean FSC
(forward light scatter) value in the presence of PEG molecules of diﬀerent hydrodynamic radii.
demonstrated to be independent [7, 24]. Fusion proteins
tested alone did not generate entry of Ca2+ (not shown)
and ethidium (Figure 2(c)). Ethidium entry showed a higher
variation than what was observed for calcium, but the fusion
proteins retained signiﬁcant biological activity (Figure 2(c)).
The activity of GST∼LukS-PV + LukF-PV lies between those
obtained for PVL and for PVL with a 1 : 10 dilution of LukS-
PV, whereas the activity of LukS-PV + GST∼LukF-PV was
similar to that of PVL with the 1 : 10 dilution of LukS-
PV (Figure 2(c)). The combination of both fusion proteins
showed a considerably reduced ethidium inﬂux, even if com-
pared with the 1 : 10 dilution of LukS-PV (Figure 2(c)).6 Journal of Biomedicine and Biotechnology
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Figure 3: Oligomers formed by PVL and modiﬁed toxins.
Oligomers were checked in solution or after recovery from treated
human PMNs, 3–8% (w/v) SDS-PAGE and immunoblotting with
anti-LukS-PVandanti-LukF-PVaﬃnity-puriﬁedrabbitantibodies.
Lane 1: LukS-PV + LukF-PV without membranes, lane 2: PMNs
only, lane 3: GST∼LukS-PV + GST∼L u k F - P V ,l a n e s4 ,5 ,6 :t o x -
ins applied on PMNs membranes and then saponin/glutaraldehyde
treated and heated 5 minutes at 100◦C as described in materials and
methods,lane4:LukS-PV+GST∼LukF-PV,lane5:GST∼LukS-PV
+L u k F - P V ,l a n e6 :G S T ∼LukS-PV + GST∼LukF-PV.
Thisdiﬀerencecanagainbeexplainedbythesterichindrance
causedbyGSTmolecules.AfterosmoticprotectionwithPEG
molecules, all couples involving at least one fusion protein
showed decays of the forward light scatter values comparable
to those of the WT toxin (Figure 2(d)). The inﬂexion point
calculated for each curve clearly indicated permeability to
PEG molecules with a hydrodynamic radius cutoﬀ between
1.12 and 1.2nm. Thus, the diameter of the leukotoxin pores
was not aﬀected by GST fusion proteins [25].
We aimed at identifying oligomers formed by the fu-
sion proteins (67 and 60kd, resp.) within the human PMNs
membranes to conﬁrm the pore formation. When retrieved
from cell membranes, we noticed that oligomers formed
by LukS-PV and LukF-PV were very sensitive to detergents
(saponin 1% and SDS 0.04%), as we only detected mixtures
of monomers and dimers (Figure 3,l a n e3 ) .T h e r e f o r e ,w e
used a cross-linking agent, glutaraldehyde, applied consec-
utively after the saponin treatment, to help to stabilize the
oligomers removed from the membranes in the presence of
an excess of cell membrane proteins. Cross-linking proved
eﬃcient for both combination of fusion proteins (Figure 3,
lanes 4–6), but essentially showed tetramers for all, in spite
of the fact that hexamers might be suspected for the LukS-
PV + GST∼LukF-PV combination (Figure 3,l a n e4 ,s e ea r -
row). The use of anti-LukS-PV and anti-LukF-PV antibod-
ies, alone or in combination, allowed the detection of sim-
ilar high molecular mass oligomers containing GST fusion
leukotoxins(datanotshown).Thematerialswerespeciﬁcfor
the leukotoxins, since no immunoreactive product was ob-
served when analyzing human PMNs alone (Figure 3,l a n e
2). The intensity of these bands rapidly decreased while the
12 3456789
94kd
67kd
43kd
30kd
Figure4:Controlofhomogeneityandabsenceofsigniﬁcantdimer-
ization in nonreducing conditions by 3–8% (w/v) SDS-PAGE of
200ng of each mutated protein: lane 1: molecular ladder, lane 2:
LukF-PV, lane 3: LukF-PV T5C-T21C oxidized (ox), lane 4: LukF-
PV S8C-K20Cox, lane 5: molecular ladder, lane 6: LukS-PV, lane 7:
LukS-PV-1C-R16Cox, lane 8: LukS-PV D1C-R16Cox, lane 9: LukS-
PV N2C-R16Cox.
number of subunits increased. The increase of the steric hin-
drance due to the fusion GST proteins probably contributes
to the intrinsic instability of leukotoxins pores when ex-
tracted from membranes and may impact the resolution of
the complete oligomers (Figure 3, lanes 4–6). Therefore, we
decided to characterize the oligomers for only WT proteins
and double cysteine mutants (see below).
3.2. Integrityofdouble-cysteinemutants
Double-cysteine mutants were analyzed in their oxidized
forms (Figure 4).AmongtheLukS-PVandLukF-PVdouble-
cysteine mutants obtained in either reducing or oxidizing
conditions, only oxidized LukS-PV N2C-R16C and oxidized
LukF-PV T5C-T21C contained very small amounts of ho-
modimers (< 8%). The presence of these dimers did not
cause a signiﬁcant loss of biological activity.
Once puriﬁed, proteins were kept in 10mM DTT. Af-
ter desalting, titration of accessible thiols with DTNB ranged
from 85 to 97% of free thiols, depending on the mutants. Af-
ter oxidation, accessible thiol residues in oxidized LukS-PV-
1C-R16C,D1C-R16C,N2C-R16C,andLukF-PVT5C-T21C,
S8C-K20C mutants decreased to less than 1.5% (1% was the
limit of the titration assay). These mutants formed internal
disulﬁde bonds (Figure 4,l a n e s6t o9 ) .
3.3. Bindingofdouble-mutatedleukotoxins
Using similar conditions as for the fusion proteins, we deter-
mined the apparent binding constants of the diﬀerent mu-
tants to their respective ligands. For LukS-PV mutants, we
found kIapp values, ranging from 0.052nM to 0.069nM, sim-
ilar to those of WT LukS-PV. Values for the binding of LukF-
PV T5C-T21C to the LukS-PV mutants-membrane com-
plexes (kIapp = 2.8 − 5.2nM) were also close to that of the
WT protein (kIapp = 2.5nM). In contrast, binding of LukF-
PV S8C-K20C was more aﬀected. Indeed, binding of LukF-
PV S8C-K20C to LukS-PV D1C-R16C and N2C-R16C gave
kIapp of 18.5 ± 2.5a n d1 2± 2nM, respectively. Binding be-
came even worse with LukS-PV and LukS-PV(-1C)-R16C
with kIapp = 37 ±5a n d2 4±6nM, respectively.Olivier Joubert et al. 7
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Figure 5: Flow cytometry evaluation of Ca2+ entry into human PMNs for diﬀerent combinations of puriﬁed WT S and F proteins and their
oxidized double mutants. (a) Oxidized LukS-PV mutants were tested with WT LukF-PV. (b) Oxidized LukF-PV double mutants were tested
with WT LukS-PV. (c) Oxidized LukS-PV double mutants were tested with LukF-PV S8C-K20Cox. (d) Oxidized LukS-PV double mutants
were tested with LukF-PV T5C-T21Cox.
3.4. Biologicalactivitiesoftheleukotoxinmutants
Ca2+ entry
Staali et al. [7] and Baba Moussa et al. [24] showed that
Ca2+ inﬂuxandethidiumentrypromotedbyleukotoxinscan
be selectively inhibited. We evaluated the diﬀerent oxidized
LukS-PVandLukF-PVdoublemutantsfortheirabilitytoac-
tivate PMNs and provoke Ca2+-channel opening (Figure 5).
In our system, we assayed LukS-PV at 0.1 or 1nM in com-
bination with LukF-PV at 2 or 20nM, and compared activ-
ity of associations of LukS-PV proteins/mutants at 1nM and
LukF-PV proteins/mutants at 20nM. Table 1 summarizes ki-
netics of cell-associated Ca2+ ﬂuorescence for diﬀerent com-
binations. When mutants were ﬁrst combined with the het-
erologous WT protein, kinetics of Ca2+ inﬂux comparable
with that of the WT toxin were observed for combinations8 Journal of Biomedicine and Biotechnology
Table 1: Times (min) to reach (a) 5% and (b) 100% of the Fluo-3 ﬂuorescence characteristic of the cellular entry of Ca2+ due to calcium
channels activation by combinations of PVL (taken as reference) and its mutants, n.r.: not reached, n.d.: not determined.
LukF 40nM LukF 2nM LukF-T5CT21C LukF-S8CK20C
LukS 1nM 1.25(a) 3.5(a) 1.25(a) 4.5(a)
2.5(b) 10(b) (95%) 5(b) n.r.
LukS-D1CR16C 6(a)
n.d. 3.4(a) n.r.
n.r.(b) 7.5(b) (90%) n.r.
LukS-(-1C)R16C 1.25(a)
n.d. 1.75(a) n.r.
2.5(b) 5(b) n.r.
LukS-N2CR16C 1.25(a)
n.d. 1.5(a) 3(a)
2.5(b) 5(b) 7.5(b) (95%)
involving LukS-PV(-1C)-R16C or N2C-R16C and LukF-PV
at 20nM (Figure 5(a)). In contrast, the kinetics for 1nM
LukS-PV D1C-R16C combined with LukF-PV was decreased
to a lower value than that obtained for WT combination in-
volving 2nM of LukF-PV. The same was observed for LukS-
PV+LukF-PVS8C-K20C,whereasthecombinationsinvolv-
ing LukF-PV T5C-T21C were almost as active as the WT
toxin (Figure 5(b), Table 1). Greater variations in Ca2+ in-
duction were obtained when associating oxidized mutants
with each other (Figures 5(c) and 5(d)). Among the combi-
nations involving LukF-PV S8C-K20C, only LukS-PV N2C-
R16C signiﬁcantly induced Ca2+ inﬂux. The combinations
of LukS-PV(-1C-R16C) and N2C-R16C with LukF-PV T5-
T21C produced kinetics almost similar to the WT toxin, and
the combination involving LukS-PV D1C-R16C showed a
better Ca2+ inﬂux than its combination with LukS-PV (Fig-
ures 5(a) and 5(d), Table 1). Altogether, these data indicate
that constraining N-terminal extremities might not be detri-
mental to biological activity.
Ethidiumentryinducedbyporeformation
Pore formation and ethidium entry promoted by the oxi-
dized mutated proteins were more variable than Ca2+ en-
try (Figure 6). Table 2 summarizes kinetics of cell-associated
ethidiumﬂuorescencefordiﬀerentcombinations.Aftercom-
bining with WT LukF-PV, LukS-PV N2C-R16C remained as
active as WT LukS-PV, while LukS-PV(-1C)-R16C only re-
tained 1 : 10 of activity (Figure 6(a), Table 2) and kinetics for
LukS-PV D1C-R16C was dramatically aﬀected. The kinetics
ofethidiumentryinducedbyLukS-PVcombinedwithLukF-
PV mutants was intermediate between those produced by a
same concentration of LukF-PV and its 1 : 10 dilution. Com-
binationsofreducedmutantswithheterologousWTproteins
or mutants did not show high diﬀerence in activity com-
pared to the use of oxidized mutants (data not shown). Fig-
ures 6(c) and 6(d) show the results obtained for combina-
tionsofoxidizedandreducedmutants.ExceptforLukS-PV(-
1C)-R16C + LukF-PV T5C-T21C (Figure 6(c)), the associa-
tionsofreducedmutantsalwaysinducedhigherethidiumin-
ﬂuxes than those obtained with associations of oxidized mu-
tants (Table 2). From combining oxidized mutants, the pairs
involving LukS-PV(-1C)-R16C, N2C-R16C, combined with
LukF-PV T5C-T21C showed intermediate activity (Table 2),
while only LukS-PV N2C-R16C combined with LukF-PV
S8C-K20C could be considered as signiﬁcant as the last cited
(Figure 6(d)). It has to be noticed that all combinations of
oxidized mutants less prone to induce Ca2+ inﬂux were also
less eﬀective in pore formation.
Pore radii
The pore radii of the most active oxidized leukotoxins were
evaluated by osmotic protection induced with calibrated
PEG molecules (Figure 7). PMNs were protected against os-
motic disruption by PEG molecules having a hydrodynamic
diameter between 1.12nm and 1.22nm. A same value rang-
ing 1.2nm was obtained for the WT toxin, indicating similar
pore radii of these toxins.
3.5. Panton-Valentineleucocidinoligomers
Several experiments were carried out, checking for the re-
covery, the stability, and the occurrence of oligomers formed
by PVL. Control of cells without PVL did not give evi-
dence of cross-reacting material (Figure 8, lane 1). Challeng-
ing PVL oligomers with 4ng of each component in solu-
tion was highly dependent on glutaraldehyde concentrations
(Figure 8, lanes 3 and 4), while they show a little tendency
to spontaneously form dimers (lane 2). Indeed, the use of
0.3mM glutaraldehyde allowed to obtain various oligomers
containing 2 to 10 units, at least, whereas 3mM applied on
these puriﬁed proteins dramatically aﬀected signals (lane 4).
Application of 30ng of PVL per assay to PMNs only allowed
observing few dimers in the described conditions without
any glutaraldehyde treatment (Figure 8, lane 5). It has to be
noticed that a nonboiled, but SDS-containing, assay resulted
in insuﬃciently denatured materials, and even if treated
by saponin and glutaraldehyde, this did not give inter-
pretable results (Figure 8, lane 6). Saponin treatment of cells
largely helped the release of protein-containing oligomers,
despite the fact that saponin brought contaminating pro-
teins (50% of the total bulk of proteins). Each assay on cells
involve an original volume of 1mL further concentrated to
100μL. Cells treated with PVL, saponin, and with a consec-
utive cross-linking with 3% (v/v) glutaraldehyde allowed toOlivier Joubert et al. 9
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Figure 6: Flow cytometry evaluation of ethidium entry into human PMNs for diﬀerent combinations of puriﬁed WT S and F proteins
and their oxidized or reduced double mutants. (a) Oxidized LukS-PV mutants were ﬁrst tested with WT LukF-PV. (b) Oxidized LukF-PV
mutantsweretestedwithWTLukS-PV.(c)OxidizedorreducedLukS-PVdoublemutantsweretestedwithLukF-PVS8C-K20C.(d)Oxidized
or reduced LukS-PV double mutants were tested with LukF-PV T5C-T21C.
identify oligomers species provided that samples were boiled
(Figure 8, lanes 7–11), whether saponin treatment was car-
r i e do u ta t4 ◦Co r2 3 ◦C. In fact, the Schiﬀ reaction promoted
byglutaraldehydeisnotstableinaqueoussolution,butcross-
linking certainly occurs in our assays through the Michael
addition reaction onto amine groups (R-NH2). Considering
the excess of proteins in lysates, the observed oligomers are
assumed as preformed oligomers, since the cross-linking re-
action cannot be considered to be speciﬁc of the PVL pro-
teins. This addition reaction was stopped by ethanolamine10 Journal of Biomedicine and Biotechnology
Table 2: Times (min) to reach (a) 5%, (b) 50%, and (c) 100% of the entry of ethidium into cells by pores formed by combinations of PVL
(taken as reference) and its mutants.
LukF 40nM LukF 2nM LukF-T5C-T21C LukF-S8C-K20C
LukS 1nM
4(a) 15(a) 9.6(a) 9.6(a)
9.6(b) 31(b) 18.5(b) 18.5(b)
25(c) 48(c) 35(c) 35(c)
LukS 0.1nM
6(a)
n.d. n.d. n.d. 12.5
35
LukS-D1C-R16C
22(a)
n.d.
12(a) 22(a)
45.5(b) 28(b) 36(b)
70(c) 45.4(c) 50.2(c)
LukS-(-1C)-R16C
6(a)
n.d.
6.5(a) 22(a)
12.5(b) 17(b) 36(b)
30(c) 40(c) 48.8(c)
LukS-N2C-R16C
2(a)
n.d.
6.5(a) 3(a)
8.6(b) 17(b) 15(b)
25(c) 40(c) 35(c)
introduced in the loading buﬀer and heating in order to
minimize the cross-linking duration. Figure 8,l a n e s7a n d
8 reveal bands corresponding to any intermediates between
monomers and octamers that were recognized by anti-LukS-
PV and/or (data not shown) anti-LukF-PV aﬃnity-puriﬁed
antibodies. In fact, instable oligomers obtained after extrac-
tion from membranes with saponin might have been stabi-
lized by using cross-linking via glutaraldehyde. The quan-
tity of oligomers recovered was greater for WT toxin and
the most biologically active combination of PVL double mu-
tants (Figure 8, lanes 10 and 11) than for the less active one
(Figure 8, lane 9) and remained signiﬁcant compared to PVL
oligomers in solution (Figure 8,l a n e3 ) .
4. DISCUSSION
Although staphylococcal α-toxin and bipartite leukotoxins
fold in a comparable way, diﬀerences exist in the sequences
and structures of these two subfamilies of toxins that imply
diﬀerences in function [30]. Another distinction is in stoi-
chiometry. Indeed, α-toxin is known to form heptamers in
target cells [20] and hexamers in some diﬀerent membranes
[31]. Recently, octamers were identiﬁed in synthetic bilayers
and PMNs membrane by using cross-linking between mu-
tated components of gamma-hemolysin [5, 32]. Moreover,
the presence of strictly alternating S and F proteins was re-
cently proven in the case of leukotoxin pores [33]. Consider-
ing the sequence alignment of the S and F components of
leukotoxins and of α-toxin [23], diﬀerences between these
proteins are located at the N-termini, at each side of the cen-
tral domain and in the last ﬁfty C-terminal residues. The sig-
niﬁcance of these diﬀerences with α-toxin is not understood,
so far. It has been shown that deleting the ﬁrst two residues
or labelling the N-terminal extremity of α-toxin dramatically
reduce its biological activity [34, 35]. It is also noteworthy
that leukotoxins oligomers are less stable than those of α-
toxin, hamperingtheircrystallization.Aninvestigation using
infrared spectroscopydid not give evidenceofanysigniﬁcant
modiﬁcation in the β-strands content when passing from the
soluble state to the pore formed in planar lipid membranes
[4].
In this work, we try to bring out arguments that N-
terminal extremities of leukotoxins keeping part of the β-
sandwich core during pore formation lead to functional tox-
ins, and that a large unfolding of these extremities is not
obvious. Despite the fact that the recombinant expression
system used in this study adds an N-terminal octapeptide,
the proteins that were produced retain a biological activ-
ity comparable to native toxins [24, 25]. Moreover, GST
fusions of LukS-PV or LukF-PV also proved their binding
eﬃcacy. LukS-PV∼GST + LukF-PV was only from 3 to 5
f o l d sl e s se ﬃcient than the corresponding WT proteins, and
the LukS-PV + LukF-PV∼GST was also a bit less eﬀective
than the WT couple. The binding of LukF-PV∼GST was af-
fected when tested on its GST fusion counterpart protein
and the resulting biological activity signiﬁcantly decreased,
but remained biologically active. Thus, the decrease in bind-
ing might be due to steric hindrance produced by the fu-
sion, especially in the case of the GST couple. Despite a
higher sensitivity of the Ca2+ entry assay, the decrease of
Ca2+ inﬂux induced by the GST couple correlated with its
lower pore-forming activity. It can be assumed, therefore,
thatthedecreaseinpore-formingactivityresultsfromthere-
duced binding of LukF-PV∼GST (Figure 2(c)). Taking into
account all these features, it becomes less realistic that N-
terminal extremities of leukotoxins extensively unfold to in-
teract with residues of adjacent monomers located within
the lumen of the pore (see Figure 1). Comparatively, the ex-
pressed and puriﬁed GST∼ α-toxin has no signiﬁcant ac-
tivity against rabbit red blood cells, whereas when GST isOlivier Joubert et al. 11
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Figure 7: Determination of the hydrodynamic radius of pores
formed by the diﬀerent combinations of oxidized LukS-PV (20nM)
andLukF-PV(100nM)mutants30minutesafterapplicationoftox-
ins to human PMNs. Osmotic protection was assessed by variations
of the mean FSC (forward light scatter) value in the presence of
polyethylene glycol molecules of diﬀerent hydrodynamic radii. (a)
Oxidized LukS-PV double mutants were tested with LukF-PV S8C-
K20Cox. (b) Oxidized LukS-PV double mutants were tested with
LukF-PV T5C-T21Cox.
cleaved, the resulted octapeptide-α-toxin shows a lytic activ-
ity diminished by more than 10 folds than that of the native
α-toxin puriﬁed from S. aureus. This constitutes a functional
diﬀerence with the Panton-Valentine leucocidin. Moreover,
at least LukF-PV was not sensitive to deletions less than 10
amino acids [36, 37].
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Figure 8: Oligomers formed by PVL and modiﬁed toxins.
Oligomers were checked in solution or after recovery from treated
human PMNs, 3–8% (w/v) SDS-PAGE and immunoblotting with
anti-LukS-PV and anti-LukF-PV aﬃnity-puriﬁed rabbit antibod-
ies. Lane 1: PMNs only, lane 2: LukS-PV + LukF-PV in solu-
tion (4ng each), lane 3: LukS-PV + LukF-PV (4ng each/load)
treated by 0.3mM glutaraldehyde, lane 4: LukS-PV + LukF-PV
saponin/treated with 3mM glutaraldehyde. Lanes 5–11: each PVL
components (30ng each/load) was applied on PMNs, lane 5: LukS-
PV + LukF-PV saponin treated, lane 6: LukS-PV + LukF-PV
saponin- and glutaraldehyde treated without heating at 100◦C, lane
7: LukS-PV + LukF-PV saponin at 0◦C/glutaraldehyde treated and
boiling at 100◦C, lanes 8–11: toxins applied on PMNs, saponin
treatmentatroomtemperature+1mMglutaraldehydeandboiling,
lane 8: LukS-PV + LukF-PV, lane 9: LukS-PV-1C-R16C + LukF-PV
S8C-K20C, lane 10: LukS-PV N2C-R16C + LukF-PV S8C-K20C,
lane 11: LukS-PV + LukF-PV oxidized.
Inthesecondapproachusedinthisstudy,N-terminalex-
tremities of both PVL components were locked to the pro-
tein core by disulﬁde bonds via site-directed mutagenesis.
Diﬀerent locations for cysteine substitution were chosen for
each protein. The very ﬁrst residues and R16 of LukS-PV
appeared as good candidates for substitution by cysteines
and subsequent bridging. Indeed, although the ﬁrst two N-
terminal residues are absent in the three-dimensional struc-
ture of LukS-PV [23], three positions were chosen by anal-
ogy with LukF-PV which produced internal disulﬁde bonds
in majority. Thus, formation of homodimers during assisted
oxidation could not be responsible for a great decrease in
the biological activity of the mutated toxins. Oxidation with
30mM H2O2 could alternatively be preferred to Cu2+ ox-
idation for some mutants, but in any case, excess of oxi-
dant was removed before any biological assays. The binding
of oxidized LukS-PV mutants to human PMNs was not af-
fected, but that of LukF-PV S8C-K20C to LukS-PV mutants
was diminished from 6 to 15 folds compared to that of WT
proteins. This may suggest some modiﬁcations in the over-
all structures and some adverse compatibilities between new
structures.
In fact, when combined with LukS-PV, LukF-PV S8C-
K20C showed diminishing both in Ca2+ induction (> 10
folds) and in pore formation (less than 10 folds), but
activities largely decreased for combinations with LukS-PV12 Journal of Biomedicine and Biotechnology
D1C-R16C or (-1C)-R16C while they remained signiﬁcant
for the combination with LukS-PV N2C-R16C. Therefore, it
can be assumed that LukS-PV N2C-R16C may harbor func-
tionality similar to LukS-PV, and that the decrease in bio-
logical activities observed for the couples described above is
mainlyduetothedecreaseinbindingofLukF-PVS8C-R16C.
In the case of LukF-PV T5C-T21C, the D1C-R16C muta-
tion aﬀects biological activities in any combinations. Never-
theless, LukF-PV T5C-T21C combined with LukS-PV(-1C)-
R16C or LukS-PV N2C-R16C induced Ca2+ activations and
pore formation that only decreased to 3–5 times those of the
WT toxins, and thus considering the rigidity introduced into
structures confers functions comparable to those of PVL.
To complete our study, we investigated the stoichiome-
try and the hydrodynamic diameter of the pores. One ma-
jor diﬀerence between the pores formed by leukotoxins com-
pared to those formed by α-toxin is their instability when ex-
tracted from target membranes [20, 25]. The use of a dedi-
cated procedure involving the pores excised from cell mem-
branes and the rapid cross-linking with glutaraldehyde al-
lowed us to identify the variety of possible oligomers with-
out a further creation of monomer-monomer interaction,
thanks to the 1 × 100 weight excess of membrane proteins.
Hence, a clear indication that octamers are formed by PVL
on its target cells has been obtained, whatever the com-
bination of mutated proteins considered. This observation
strengthens those works published recently about another
leukotoxin onto synthetic membranes [5]. Though our data
suggest signiﬁcant amounts of natural octamers, no indi-
cation remains available whether hexamers and heptamers
are functional [32]. Osmotic protection of pores using PEG
molecules evoked hydrodynamic radii of about 1.2nm, in
agreement with previous data [4, 24, 25], and indicates com-
parable protections for both WT and mutated toxins.
In conclusion, none of the observations obtained in
this work favor a large unfolding and the structural loca-
tion for interactions with two adjacent protomers along the
lumen of the pore for the N-terminal extremities of the
Panton-Valentine leucocidin and, probably other bipartite
leucotoxin-constituting proteins [24], as it is the case of the
related α-toxin (Figure 1(b))[ 20]. Recent data have sug-
gested that the N-terminal extremity of α-toxin is probably
notexclusivelyrequiredintheoligomerassemblydespitethat
binding of α-toxin truncates onto membranes remains to
be quantiﬁed [38]. Other truncates of HlgC and HlgB indi-
cated that the formation of gamma-hemolysin oligomer may
support the removing of the ﬁrst 18 amino acids residues
[39]. Slight conformational modiﬁcation of these extrem-
ities during pore formation by bipartite leukotoxins could
not be excluded. Constraints via disulﬁde bonds described
in this work support functionality of the modiﬁed toxins
which has been quantitatively compared. These oligomers
clearly promote octameric bipartite pores comparable to WT
ones in target cells, even rigidity brought into molecules
by these constraints may have lowered some steps in pore-
formation process. The next structure determination of as-
sembled S and F proteins may shed new light on the role of
their N-termini on the assembly of leukotoxins while they
remain domains candidates for substitution by active pro-
teins to challenge their eﬃcacy towards cells.
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